182 related articles for article (PubMed ID: 38643738)
1. Optimal probiotic combinations for treating nonalcoholic fatty liver disease: A systematic review and network meta-analysis.
Yang Y; Yang L; Wu J; Hu J; Wan M; Bie J; Li J; Pan D; Sun G; Yang C
Clin Nutr; 2024 Jun; 43(6):1224-1239. PubMed ID: 38643738
[TBL] [Abstract][Full Text] [Related]
2. Assessment of optimal combinations of therapeutic probiotics for depression, anxiety, and stress.
Yang Y; Yang L; Wan M; Pan D; Sun G; Yang C
Psychol Med; 2024 Mar; ():1-15. PubMed ID: 38497101
[TBL] [Abstract][Full Text] [Related]
3. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Loman BR; Hernández-Saavedra D; An R; Rector RS
Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
[TBL] [Abstract][Full Text] [Related]
4. Probiotics Reduce Mortality and Morbidity in Preterm, Low-Birth-Weight Infants: A Systematic Review and Network Meta-analysis of Randomized Trials.
Morgan RL; Preidis GA; Kashyap PC; Weizman AV; Sadeghirad B;
Gastroenterology; 2020 Aug; 159(2):467-480. PubMed ID: 32592699
[TBL] [Abstract][Full Text] [Related]
5. The Benefit of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: A Meta-analysis of Randomized Control Trials.
Gkiourtzis Ν; Kalopitas G; Vadarlis A; Bakaloudi DR; Dionysopoulos G; Karanika E; Tsekitsidi E; Chourdakis M
J Pediatr Gastroenterol Nutr; 2022 Sep; 75(3):e31-e37. PubMed ID: 35758473
[TBL] [Abstract][Full Text] [Related]
6. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
[TBL] [Abstract][Full Text] [Related]
7. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis.
Ortiz-Lucas M; Tobías A; Saz P; Sebastián JJ
Rev Esp Enferm Dig; 2013 Jan; 105(1):19-36. PubMed ID: 23548007
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of probiotic strains for the treatment of pediatric atopic dermatitis: A systematic review and network meta-analysis.
Tan-Lim CSC; Esteban-Ipac NAR; Mantaring JBV; Chan Shih Yen E; Recto MST; Sison OT; Alejandria MM
Pediatr Allergy Immunol; 2021 Jan; 32(1):124-136. PubMed ID: 32524647
[TBL] [Abstract][Full Text] [Related]
9. Which Probiotic Is the Most Effective for Treating Acute Diarrhea in Children? A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
Li Z; Zhu G; Li C; Lai H; Liu X; Zhang L
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959871
[TBL] [Abstract][Full Text] [Related]
10. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.
Khan MY; Mihali AB; Rawala MS; Aslam A; Siddiqui WJ
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):703-715. PubMed ID: 31009401
[TBL] [Abstract][Full Text] [Related]
11. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis.
Li F; Ye J; Shao C; Zhong B
Lipids Health Dis; 2021 Feb; 20(1):22. PubMed ID: 33637088
[TBL] [Abstract][Full Text] [Related]
12. The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis.
Wang Y; Wang Y; Sun J
Bioengineered; 2022; 13(7-12):14960-14973. PubMed ID: 37105767
[TBL] [Abstract][Full Text] [Related]
13. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
Kobyliak N; Falalyeyeva T; Virchenko O; Mykhalchyshyn G; Bodnar P; Spivak M; Yankovsky D; Beregova T; Ostapchenko L
BMC Gastroenterol; 2016 Mar; 16():34. PubMed ID: 26976285
[TBL] [Abstract][Full Text] [Related]
14. Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis.
Huang L; Yu Q; Peng H; Zhen Z
Medicine (Baltimore); 2022 Dec; 101(51):e32335. PubMed ID: 36595801
[TBL] [Abstract][Full Text] [Related]
15. Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Yang R; Shang J; Zhou Y; Liu W; Tian Y; Shang H
Expert Rev Gastroenterol Hepatol; 2021 Dec; 15(12):1401-1409. PubMed ID: 34877910
[TBL] [Abstract][Full Text] [Related]
16. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
[TBL] [Abstract][Full Text] [Related]
17. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis.
Amini-Salehi E; Hassanipour S; Keivanlou MH; Shahdkar M; Orang Goorabzarmakhi M; Vakilpour A; Joukar F; Hashemi M; Sattari N; Javid M; Mansour-Ghanaei F
Nutr Rev; 2024 May; 82(6):815-830. PubMed ID: 37550264
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis.
Feng JR; Wang F; Qiu X; McFarland LV; Chen PF; Zhou R; Liu J; Zhao Q; Li J
Eur J Clin Pharmacol; 2017 Oct; 73(10):1199-1208. PubMed ID: 28681177
[TBL] [Abstract][Full Text] [Related]
19. The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.
Nie Q; Li M; Huang C; Yuan Y; Liang Q; Ma X; Qiu T; Li J
J Transl Med; 2024 Mar; 22(1):225. PubMed ID: 38429794
[TBL] [Abstract][Full Text] [Related]
20. Use of probiotics, prebiotics, and synbiotics in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Rong L; Ch'ng D; Jia P; Tsoi KKF; Wong SH; Sung JJY
J Gastroenterol Hepatol; 2023 Oct; 38(10):1682-1694. PubMed ID: 37409560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
